首页> 外文期刊>Social Biology >Obesity and metabolic outcomes in a safety-net health system
【24h】

Obesity and metabolic outcomes in a safety-net health system

机译:安全网卫生系统中的肥胖和代谢结果

获取原文
获取原文并翻译 | 示例
       

摘要

In the United States, obesity has increased in prevalence over time and is strongly associated with subsequent outcomes such as diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). It is unclear, however, as to how the magnitude of NAFLD risk from obesity and DM is increased in safety-net health system settings. Among the San Francisco Health Network (SFHN) patients (N = 47,211), we examined the association between Body Mass Index (BMI) and elevated liver enzyme levels, including interaction by DM status. Our findings revealed that 32.2 percent of SFHN patients were obese, and Pacific Islanders in the safety-net had the highest rates of obesity compared to other racial groups, even after using higher race-specific BMI cutoffs. In SFHN, obesity was associated with elevated liver enzymes, with the relationship stronger among those without DM. Our findings highlight how obesity is a stronger factor of NAFLD in the absence of DM, suggesting that practitioners consider screening for NAFLD among safety-net patients with obesity even if DM has not developed. These results highlight the importance of directing efforts to reduce obesity in safety-net health systems and encourage researchers to further examine effect modification between health outcomes in such populations.
机译:在美国,肥胖症随着时间的推移而普遍存在,与糖尿病(DM)和非酒精脂肪肝病(NAFLD)等后续结果强烈有关。然而,目前尚不清楚,关于肥胖症和DM的NAFLD风险的大小在安全净健康系统设置中增加。在旧金山健康网络(SFHN)患者中(N = 47,211),我们检查了体重指数(BMI)和肝酶水平升高的关联,包括DM状态的相互作用。我们的调查结果显示,32.2%的SFHN患者肥胖,安全网的太平洋岛民与其他种族群体相比,肥胖率最高,即使在使用更高的种族特异性BMI截止后也是如此。在SFHN中,肥胖与肝酶升高有关,在没有DM的情况下具有更强的关系。我们的调查结果强调了肥胖是如何在没有DM的情况下是NAFLD的更强度因素,表明,即使DM尚未开发,从业者也考虑安全净患者的肥胖患者的NAFLD。这些结果突出了指导努力减少安全净卫生系统中肥胖的重要性,并鼓励研究人员进一步审查这种人群的健康结果之间的效果修改。

著录项

  • 来源
    《Social Biology》 |2020年第3期|257-267|共11页
  • 作者单位

    School of Public Health UCLA Center for Health Policy Research Los Angeles California USA;

    School of Public Health Division of Epidemiology and Biostatistics University of California Berkeley California USA;

    Department of Medicine Division of Gastroenterology University of California San Francisco CA USA UCSF Liver Center San Francisco California USA;

    Alameda County Behavioral Health Oakland California USA;

    Department of Medicine Division of Gastroenterology University of California San Francisco CA USA Center for Vulnerable Populations University of California San Francisco California USA;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 21:10:16

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号